Abstract
Introduction: Chronic kidney disease (CKD) is associated with increased cardiovascular risk and mortality. We evaluated whether stage 3 (s3)-CKD is associated with abnormalities of the cardiovascular system.
Methods: Thirty-nine asymptomatic s3-CKD patients, free of prevalent cardiovascular disease, were compared with 44 control subjects with comparable prevalence of hypertension (66% vs 69% in s3-CKD). In addition to standard echocardiographic parameters, we computed non-invasive effective arterial elastance (EAE, in mmHg/mL/beat), systolic left ventricular elastance (LVe, in mmHg/mL) and myocardial mechanic efficiency (MME, in mL/sec), using previously reported formulas.
Results: s3-CKD and controls were comparable for age, sex, lipid profile and prevalence of diabetes mellitus and smoking habit. Left ventricular (LV) mass, geometry and stroke work were similar in the two groups, with both ejection fraction and midwall shortening (mS) significantly reduced in the CKD group (both p < 0.001). Within the s3-CKD group, 36% had clear-cut depressed mS. EAE and peripheral resistance were higher in s3-CKD than in controls (both p < 0.005), and MME was reduced in CKD (p < 0.005), an impairment even clearer after controlling for LV mass, and increasing with increasing values of LV mass (p < 0.001). In addition, at a given level of peripheral resistance, LV geometry was less concentric in s3-CKD than in controls (p < 0.05).
Conclusions: s3-CKD asymptomatic patients show a peculiar cardiovascular phenotype, characterized by impaired mechano-energetic efficiency and reduced midwall mechanics, in the presence of inadequately compensating LV concentric remodelling. Whether these characteristics might result in higher cardiovascular risk in s3-CKD should be investigated.
Similar content being viewed by others
References
White SL, Cass A, Atkins RC, et al. Chronic kidney disease in the general population. Adv Chronic Kidney Dis 2005; 12: 5–13
Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intern Med 2003; 139: 137–47
Go A, Chertow G, Fan D, et al. Chronic kidney disease and risk of death, cardiovascular events and hospitalization. N Engl J Med 2004; 351: 1296–305
Duru OK, Vargas RB, Kermah D, et al. High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine. J Gen Intern Med 2009; 24: 86–92
de Simone G, Devereux RB, Koren MJ, et al. Midwall left ventricular mechanics: an independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996; 93: 259–65
Schillaci G, Pasqualini L, Verdecchia P, et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 2002; 39: 2005–11
Zoccali C, Benedetto FA, Mallamaci F, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12: 2768–74
Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 1993; 88: 1444–55
Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–8
de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251–60
de Simone G, Devereux RB, Daniels SR, et al. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056–62
de Simone G, Devereux RB, Ganau A, et al. Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography. Am J Cardiol 1996; 78: 801–7
de Simone G, Devereux RB, Roman MJ, et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension [published erratum appears in J Am Coll Cardiol 1994; 24: 844]. J Am Coll Cardiol 1994; 23: 1444–51
Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009 Feb; 22: 107–33
Rozich JD, Carabello BA, Usher BW, et al. Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Circulation 1992; 86: 1718–26
Kelly RP, Ting CT, Yang TM, et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992; 86: 513–52
de Simone G, Chinali M, Galderisi M, et al. Myocardial mechano-energetic efficiency in hypertensive adults. J Hypertens 2009; 27: 650–5
de Simone G, Devereux R, Daniels SR, et al. Gender differences in left ventricular growth. Hypertension 1995; 26: 979–83
Zoccali C. Cardiovascular risk in patients with chronic kidney disease: not high enough to enter the major league? Curr Hypertens Rep 2008; 10: 1–2
Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186–92
Wheeler DC, Townend JN, Landray MJ. Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study. Kidney Int Suppl 2003; 63: 201–3
Wachtell K, Palmieri V, Olsen MH, et al. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with echocardiographic left ventricular hypertrophy. Am Heart J 2002; 143: 319–26
Leoncini G, Viazzi F, Conti N. Renal and cardiac abnormalities in primary hypertension. J Hypertens 2009; 27: 1064–73
de Simone G, Devereux RB, Celentano A, et al. Left ventricular chamber and wall mechanics in the presence of concentric geometry. J Hypertens 1999; 17: 1001–6
Aurigemma GP, Silver KH, Priest MA, et al. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995; 26: 195–202
de Simone G, Devereux RB. Rationale of echocardiographic assessment of left ventricular wall stress and midwall mechanics in hypertensive heart disease. Eur J Echocardiogr 2002; 3: 192–8
Chinali M, de Simone G, Matteucci MC, et al. Reduced systolic myocardial function in children with chronic renal insufficiency. J Am Soc Nephrol 2007; 18: 593–8
Zoccali C, Benedetto FA, Tripepi G. Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study. J Am Soc Nephrol 2006; 17: 1460–5
Salvetti M, Muiesan ML, Paini A, et al. Myocardial ultrasound tissue characterization in patients with chronic renal failure. J Am Soc Nephrol 2007; 18: 1953–8
Chinali M, Aurigemma GP, Trivedi D, et al. Depressed cardiac mechanics in patients with chronic renal insufficiency: a speckle-strain study [abstract]. American Society of Hypertension Annual Meeting; 2010 May 1–4; New York
Haydar A, Covic A, Colhoun H, et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Nephrol Dialysis Transpl 2004; 19: 2307–12
Acknowledgements
No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Morgillo, T., Chinali, M., Pota, A. et al. Preclinical Systolic Dysfunction in Patients with Stage 3 Chronic Kidney Disease. High Blood Press Cardiovasc Prev 17, 59–64 (2010). https://doi.org/10.2165/11311810-000000000-00000
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2165/11311810-000000000-00000